Detalhe da pesquisa
1.
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Hum Mol Genet
; 23(9): 2440-6, 2014 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24334767
2.
Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.
Oncotarget
; 6(32): 32955-65, 2015 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26460615
3.
SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
J Clin Endocrinol Metab
; 100(2): E287-91, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25405498
4.
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.
Nat Commun
; 6: 8784, 2015 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-26522426
5.
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
Nat Commun
; 6: 6044, 2015 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-25625332
6.
Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome.
J Clin Endocrinol Metab
; 99(2): E369-73, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24276449
7.
SDH mutations establish a hypermethylator phenotype in paraganglioma.
Cancer Cell
; 23(6): 739-52, 2013 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-23707781